Related Experiment Videos
Cytokines and fibrogenesis.
1Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Seminars in Liver Disease
|July 28, 1999
Summary
Cytokines are key drivers of liver fibrosis, a condition where the liver heals from injury. Targeting these cytokines and hepatic stellate cells offers promising therapeutic strategies for liver fibrosis.
Area of Science:
- Hepatology
- Cell Biology
- Immunology
Background:
- Hepatic fibrosis results from the liver's wound-healing response to chronic injury.
- Cytokines are crucial signaling molecules influencing fibrogenesis (scar tissue formation).
- Hepatic stellate cells (HSCs) are central to the fibrotic process, acting as both sources and targets of cytokines.
Purpose of the Study:
- To elucidate the multifaceted roles of cytokines in hepatic fibrogenesis.
- To define the critical involvement of hepatic stellate cells in cytokine-mediated liver fibrosis.
- To explore therapeutic potential by modulating cytokine actions.
Main Methods:
- Review and synthesis of existing research on cytokine roles in liver fibrosis.
- Analysis of HSC activation pathways and their interaction with cytokines.
- Framework development to understand cytokine regulation in fibrogenesis.
Main Results:
- Cytokines can be either pro- or antifibrogenic, with autocrine, paracrine, and matrix-bound sources being significant.
- HSC activation involves a transition from a resting to a proliferative, contractile, and fibrogenic state, losing vitamin A.
- Key features of HSC activation include proliferation, contractility, fibrogenesis, extracellular matrix degradation, chemotaxis, cytokine release, and retinoid loss.
Conclusions:
- Cytokine actions are pivotal in driving hepatic fibrosis through HSC activation.
- Understanding HSC behavior and cytokine regulation provides a basis for novel therapeutic interventions.
- Targeting cytokine pathways offers realistic hope for treating liver fibrosis.